Financial reports
10-K
2023 FY
Annual report
1 Apr 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
ARS
2022 FY
Annual report to shareholders
5 May 23
10-K
2022 FY
Annual report
10 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
28 Mar 22
Current reports
8-K
Cingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update
1 Apr 24
8-K
Other Events
18 Mar 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
26 Feb 24
8-K
Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors
13 Feb 24
8-K
Cingulate Announces Pricing of $7.5 Million Public Offering
7 Feb 24
8-K
Entry into a Material Definitive Agreement
29 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
28 Dec 23
8-K
Departure of Directors or Certain Officers
15 Dec 23
8-K
Departure of Directors or Certain Officers
12 Dec 23
8-K
Material Modifications to Rights of Security Holders
28 Nov 23
Registration and prospectus
S-8
Registration of securities for employees
4 Apr 24
424B4
Prospectus supplement with pricing info
3 Apr 24
POS AM
Prospectus update (post-effective amendment)
1 Apr 24
424B5
Prospectus supplement for primary offering
18 Mar 24
424B4
Prospectus supplement with pricing info
5 Feb 24
S-1/A
IPO registration (amended)
29 Jan 24
S-1
IPO registration
12 Jan 24
RW
Registration withdrawal request
6 Dec 23
S-1
IPO registration
15 Nov 23
424B4
Prospectus supplement with pricing info
12 Sep 23
Other
EFFECT
Notice of effectiveness
3 Apr 24
EFFECT
Notice of effectiveness
5 Feb 24
CORRESP
Correspondence with SEC
30 Jan 24
CORRESP
Correspondence with SEC
30 Jan 24
UPLOAD
Letter from SEC
18 Jan 24
EFFECT
Notice of effectiveness
12 Sep 23
CORRESP
Correspondence with SEC
7 Sep 23
CORRESP
Correspondence with SEC
7 Sep 23
UPLOAD
Letter from SEC
26 Jul 23
EFFECT
Notice of effectiveness
18 May 23